1 Parenteral Drugs Market Overview
1.1 Parenteral Drugs Product Scope
1.2 Parenteral Drugs Segment by Type
1.2.1 Global Parenteral Drugs Sales by Type (2020-2026)
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Parenteral Drugs Segment by Application
1.3.1 Global Parenteral Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Parenteral Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Parenteral Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Parenteral Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Parenteral Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Parenteral Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Parenteral Drugs Industry
1.5.1.1 Parenteral Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Parenteral Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Parenteral Drugs Players to Combat Covid-19 Impact
2 Parenteral Drugs Estimate and Forecast by Region
2.1 Global Parenteral Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Parenteral Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Parenteral Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Parenteral Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Parenteral Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Parenteral Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Parenteral Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Parenteral Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Parenteral Drugs Estimates and Projections (2015-2026)
2.4.3 China Parenteral Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Parenteral Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Parenteral Drugs Estimates and Projections (2015-2026)
2.4.6 India Parenteral Drugs Estimates and Projections (2015-2026)
3 Global Parenteral Drugs Competition Landscape by Players
3.1 Global Top Parenteral Drugs Players by Sales (2015-2020)
3.2 Global Top Parenteral Drugs Players by Revenue (2015-2020)
3.3 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2019)
3.4 Global Parenteral Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Parenteral Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Parenteral Drugs Players (Opinion Leaders)
4 Global Parenteral Drugs Market Size by Type
4.1 Global Parenteral Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Parenteral Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Parenteral Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Parenteral Drugs Price by Type (2014-2020)
4.2 Global Parenteral Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Parenteral Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Parenteral Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Parenteral Drugs Price Forecast by Type (2021-2026)
5 Global Parenteral Drugs Market Size by Application
5.1 Global Parenteral Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Parenteral Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Parenteral Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Parenteral Drugs Price by Application (2015-2020)
5.2 Global Parenteral Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Parenteral Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Parenteral Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Parenteral Drugs Price Forecast by Application (2021-2026)
3 North America Parenteral Drugs Market Facts & Figures
3.2 North America Parenteral Drugs Sales Market Share by Company (2015-2020)
3.3 North America Parenteral Drugs Sales Market Share by Type (2015-2020)
3.4 North America Parenteral Drugs Sales Market Share by Application (2015-2020)
4 Europe Parenteral Drugs Market Facts & Figures
4.2 Europe Parenteral Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Parenteral Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Parenteral Drugs Sales Market Share by Application (2015-2020)
5 China Parenteral Drugs Market Facts & Figures
5.2 China Parenteral Drugs Sales Market Share by Company (2015-2020)
5.3 China Parenteral Drugs Sales Market Share by Type (2015-2020)
5.4 China Parenteral Drugs Sales Market Share by Application (2015-2020)
6 Japan Parenteral Drugs Market Facts & Figures
6.2 Japan Parenteral Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Parenteral Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Parenteral Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Parenteral Drugs Market Facts & Figures
7.2 Southeast Asia Parenteral Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Parenteral Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Parenteral Drugs Sales Market Share by Application (2015-2020)
8 India Parenteral Drugs Market Facts & Figures
8.2 India Parenteral Drugs Sales Market Share by Company (2015-2020)
8.3 India Parenteral Drugs Sales Market Share by Type (2015-2020)
8.4 India Parenteral Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Parenteral Drugs Business
12.1 Ostuka Pharmaceutical
12.1.1 Ostuka Pharmaceutical Parenteral Drugs Corporation Information
12.1.2 Ostuka Pharmaceutical Parenteral Drugs Business Overview and Total Revenue
12.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
12.1.5 Ostuka Pharmaceutical Recent Development
12.2 Teva Pharmaceutical Industries
12.2.1 Teva Pharmaceutical Industries Parenteral Drugs Corporation Information
12.2.2 Teva Pharmaceutical Industries Parenteral Drugs Business Overview and Total Revenue
12.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered
12.2.5 Teva Pharmaceutical Industries Recent Development
12.3 Kelun Pharma
12.3.1 Kelun Pharma Parenteral Drugs Corporation Information
12.3.2 Kelun Pharma Parenteral Drugs Business Overview and Total Revenue
12.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Kelun Pharma Parenteral Drugs Products Offered
12.3.5 Kelun Pharma Recent Development
12.4 Cook Pharmica
12.4.1 Cook Pharmica Parenteral Drugs Corporation Information
12.4.2 Cook Pharmica Parenteral Drugs Business Overview and Total Revenue
12.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cook Pharmica Parenteral Drugs Products Offered
12.4.5 Cook Pharmica Recent Development
12.5 Patheon
12.5.1 Patheon Parenteral Drugs Corporation Information
12.5.2 Patheon Parenteral Drugs Business Overview and Total Revenue
12.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Patheon Parenteral Drugs Products Offered
12.5.5 Patheon Recent Development
12.6 BAG Healthcare
12.6.1 BAG Healthcare Parenteral Drugs Corporation Information
12.6.2 BAG Healthcare Parenteral Drugs Business Overview and Total Revenue
12.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BAG Healthcare Parenteral Drugs Products Offered
12.6.5 BAG Healthcare Recent Development
12.7 Beximco Pharma
12.7.1 Beximco Pharma Parenteral Drugs Corporation Information
12.7.2 Beximco Pharma Parenteral Drugs Business Overview and Total Revenue
12.7.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Beximco Pharma Parenteral Drugs Products Offered
12.7.5 Beximco Pharma Recent Development
12.8 Baxter Healthcare Corporation
12.8.1 Baxter Healthcare Corporation Parenteral Drugs Corporation Information
12.8.2 Baxter Healthcare Corporation Parenteral Drugs Business Overview and Total Revenue
12.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered
12.8.5 Baxter Healthcare Corporation Recent Development
12.9 B. Braun
12.9.1 B. Braun Parenteral Drugs Corporation Information
12.9.2 B. Braun Parenteral Drugs Business Overview and Total Revenue
12.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 B. Braun Parenteral Drugs Products Offered
12.9.5 B. Braun Recent Development
12.10 Fresenius
12.10.1 Fresenius Parenteral Drugs Corporation Information
12.10.2 Fresenius Parenteral Drugs Business Overview and Total Revenue
12.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Fresenius Parenteral Drugs Products Offered
12.10.5 Fresenius Recent Development
12.11 Albert David
12.11.1 Albert David Parenteral Drugs Corporation Information
12.11.2 Albert David Parenteral Drugs Business Overview and Total Revenue
12.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Albert David Parenteral Drugs Products Offered
12.11.5 Albert David Recent Development
12.12 BML Parenteral Drugs
12.12.1 BML Parenteral Drugs Parenteral Drugs Corporation Information
12.12.2 BML Parenteral Drugs Parenteral Drugs Business Overview and Total Revenue
12.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 BML Parenteral Drugs Parenteral Drugs Products Offered
12.12.5 BML Parenteral Drugs Recent Development
12.13 Pfizer (Hospira)
12.13.1 Pfizer (Hospira) Parenteral Drugs Corporation Information
12.13.2 Pfizer (Hospira) Parenteral Drugs Business Overview and Total Revenue
12.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Pfizer (Hospira) Parenteral Drugs Products Offered
12.13.5 Pfizer (Hospira) Recent Development
12.14 Pisa
12.14.1 Pisa Parenteral Drugs Corporation Information
12.14.2 Pisa Parenteral Drugs Business Overview and Total Revenue
12.14.3 Pisa Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Pisa Parenteral Drugs Products Offered
12.14.5 Pisa Recent Development
12.15 Ozon Pharmaceuticals Ltd
12.15.1 Ozon Pharmaceuticals Ltd Parenteral Drugs Corporation Information
12.15.2 Ozon Pharmaceuticals Ltd Parenteral Drugs Business Overview and Total Revenue
12.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Products Offered
12.15.5 Ozon Pharmaceuticals Ltd Recent Development
12.16 Aspen Holdings
12.16.1 Aspen Holdings Parenteral Drugs Corporation Information
12.16.2 Aspen Holdings Parenteral Drugs Business Overview and Total Revenue
12.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Aspen Holdings Parenteral Drugs Products Offered
12.16.5 Aspen Holdings Recent Development
12.17 PSI Ltd
12.17.1 PSI Ltd Parenteral Drugs Corporation Information
12.17.2 PSI Ltd Parenteral Drugs Business Overview and Total Revenue
12.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.17.4 PSI Ltd Parenteral Drugs Products Offered
12.17.5 PSI Ltd Recent Development
12.18 Wintac Limited
12.18.1 Wintac Limited Parenteral Drugs Corporation Information
12.18.2 Wintac Limited Parenteral Drugs Business Overview and Total Revenue
12.18.3 Wintac Limited Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Wintac Limited Parenteral Drugs Products Offered
12.18.5 Wintac Limited Recent Development
12.19 AXA Parenterals Ltd
12.19.1 AXA Parenterals Ltd Parenteral Drugs Corporation Information
12.19.2 AXA Parenterals Ltd Parenteral Drugs Business Overview and Total Revenue
12.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.19.4 AXA Parenterals Ltd Parenteral Drugs Products Offered
12.19.5 AXA Parenterals Ltd Recent Development
12.20 Acebright
12.20.1 Acebright Parenteral Drugs Corporation Information
12.20.2 Acebright Parenteral Drugs Business Overview and Total Revenue
12.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Acebright Parenteral Drugs Products Offered
12.20.5 Acebright Recent Development
12.21 Southwest Pharmaceutical
12.21.1 Southwest Pharmaceutical Parenteral Drugs Corporation Information
12.21.2 Southwest Pharmaceutical Parenteral Drugs Business Overview and Total Revenue
12.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Southwest Pharmaceutical Parenteral Drugs Products Offered
12.21.5 Southwest Pharmaceutical Recent Development
12.22 Abbott
12.22.1 Abbott Parenteral Drugs Corporation Information
12.22.2 Abbott Parenteral Drugs Business Overview and Total Revenue
12.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Abbott Parenteral Drugs Products Offered
12.22.5 Abbott Recent Development
13 Parenteral Drugs Manufacturing Cost Analysis
13.1 Parenteral Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Parenteral Drugs
13.4 Parenteral Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Parenteral Drugs Distributors List
14.3 Parenteral Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
【免責事項】
https://www.globalresearch.jp/disclaimer